Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-22

FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the generic drug isoniazid submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)